close

Mergers and Acquisitions

1 2 3 4 5 32
Number of results: 629
Date Acquired company Acquiring company Amount Related
2017-07-18 TomTec Imaging Systems (Germany) Philips (The Netherlands) undisclosed Technology - Services
2017-07-17 Merus Labs International (Canada) Norgine (The Netherlands) C$342 million
2017-07-10 Amatsigroup (France) Eurofins Scientific (Luxembourg) € 130 million Technology - Services
2017-07-06 Capsugel (USA - NJ) Lonza (Switzerland) $ 5.5 billion Technology - Services - Bioproduction - Manufacturing
2017-06-30 mySugr (Austria) Roche (Switzerland) undisclosed diabetes
2017-06-28 True North Therapeutics (USA - CA) Bioverativ (USA - MA) up to $825 million Genetic diseases - Rare diseases - Hematological disease
2017-06-26 Innova Biosciences (UK) Sygnis (Germany)
2017-06-26 Genoma Group (Italy) Eurofins Scientific (Luxembourg) undisclosed
2017-06-16 Actelion (Switzerland) Johnson&Johnson (J&J) (USA - NJ) $30 billion Rare diseases
2017-06-13 Alphora Research (Canada) Eurofins Scientific (Luxembourg) undisclosed Technology - Services
2017-05-30 Pharmacell (The Netherlands) Lonza (Switzerland) undisclosed Technology  - Services - Bioproduction - Manufacturing
2017-05-16 HansaBioMed Life Sciences (Estonia) Lonza (Switzerland) undisclosed Technology - Services
2017-05-09 iLab, Biosphere and two specialty clinical testing laboratories (France) Eurofins Scientific (Luxembourg) diagnostic
2017-05-04 MVZ für Laboratoriumsmedizin am Hygiene-Institut GmbH (Hygel) (Germany) Eurofins Scientific (Luxembourg) diagnostic
2017-05-04 Hygel (Germany) Eurofins Scientific (Luxembourg) undisclosed Technology - Services
2017-05-03 MiNA Therapeutics (UK) Sosei (Japan) £ 175 million Cancer - Oncology
2017-04-11 Asymptote (UK) GE Healthcare (USA - WI) undisclosed Technology - Services
2017-04-03 assets and relevant business related to the CELLSEARCH® Circulating Tumor Cell System from Janssen Diagnostics (USA - PA) Menarini-Silicon Biosystems, a Menarini group company (Italy) undisclosed Cancer - Oncology - Diagnostic
2017-03-30 Symetis (Switzerland) Boston Scientific (USA - MA) $435 million Medical devices Cardiovascular diseases
2017-03-23 Agalimmune (UK) Bioline Rx (Israel) $6 million and additional future payments based on development and commercial milestones Cancer - Oncology